TY  - GEN
AU  - Sulkowski,Mark S
AU  - Naggie,Susanna
AU  - Lalezari,Jacob
AU  - Fessel,Walford Jeffrey
AU  - Mounzer,Karam
AU  - Shuhart,Margaret
AU  - Luetkemeyer,Anne F
AU  - Asmuth,David
AU  - Gaggar,Anuj
AU  - Ni,Liyun
AU  - Svarovskaia,Evguenia
AU  - Brainard,Diana M
AU  - Symonds,William T
AU  - Subramanian,G Mani
AU  - McHutchison,John G
AU  - Rodriguez-Torres,Maribel
AU  - Dieterich,Douglas
TI  - Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection
SN  - 1538-3598
PY  - 2014///0804
KW  - Administration, Oral
KW  - Adult
KW  - Aged
KW  - Antiviral Agents
KW  - adverse effects
KW  - Coinfection
KW  - Drug Administration Schedule
KW  - Drug Therapy, Combination
KW  - Female
KW  - Genotype
KW  - HIV Infections
KW  - drug therapy
KW  - Hepacivirus
KW  - genetics
KW  - Hepatitis C
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - RNA, Viral
KW  - blood
KW  - Ribavirin
KW  - Sofosbuvir
KW  - Treatment Outcome
KW  - Uridine Monophosphate
KW  - Viral Load
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1001/jama.2014.7734
ER  -